A Win For CTI BioPharma Corp.
Thu, Dec 12, 2019 at 05:30 PM
CTI BioPharma Corp. (CTIC:NASDAQ) shot up at $1.53, representing a gain of 26.4%. On Wed 11 Dec 19, CTIC:NASDAQ touched a New 2-Week High of $1.21. The stock got featured on our News Catalysts scanner on Mon 09 Dec 19 at 11:12 AM in the 'BIOTECH' category. From Wed 20 Nov 19, the stock recorded 57.14% Up Days and 66.67% Green Days
About CTI BioPharma Corp. (CTIC:NASDAQ)
CTI BioPharma Corp is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of novel targeted therapies.
Top 10 Gainers:
- Assertio Therapeutics, Inc. (ASRT:NASDAQ), 56.65%
- Amneal Pharmaceuticals, Inc. (AMRX:NYSE), 44.83%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 44.67%
- Pacific Coast Oil Trust (ROYT:NYSE), 38.26%
- Assembly Biosciences, Inc. (ASMB:NASDAQ), 34.44%
- Ferroglobe PLC (GSM:NASDAQ), 32.6%
- LSC Communications, Inc. (LKSD:NYSE), 28.19%
- CTI BioPharma Corp. (CTIC:NASDAQ), 26.45%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 25.54%
- Top Ships Inc. (TOPS:NASDAQ), 24.48%